en · de · es
aod-9604-notes.peptides4962.com › News › Background And Development History — Questions and Answers

Background And Development History — Questions and Answers

By Editorial Desk · published 2025-09-04 · last reviewed 2025-10-12 · News

Everything below concerns AOD9604. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2025-10-12. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Development History

AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.

Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.

Identity and Research Context

AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.

Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideDerived from C-terminal region of human growth hormone
Approximate molecular massAbout 1.8 kDaVaries with sequence length and counterions
Confirmed receptor targetNone establishedNo confirmed growth hormone receptor agonism
Reported in vitro activityLipolysis stimulation and lipogenesis inhibitionObserved mainly in adipocyte models; human relevance uncertain
Regulatory statusNot approved as a drug in major marketsMay be treated differently across jurisdictions; not a recognized dietary ingredient in some countries

Background from the literature

== Sources == Douglas, James Sholto (1975). Hydroponics: The Bengal System: with Notes on Other Methods of Soilless Cultivation. Oxford University Press. ISBN 978-0-19-560530-3. Douglas, James Sholto (1985). Advanced Guide to Hydroponics. Pelham. ISBN 978-0-7207-1571-2. OCLC 1341823405. Jones Jr., J. Benton (2016). Hydroponics. doi:10.1201/9780849331671. ISBN 978-1-4200-3770-8.

David Baker online talk: "Crowd Sourcing Protein Folding: Rosetta@Home and FoldIt" Archived July 2, 2017, at the Wayback Machine David Baker online seminar: "Introduction to Protein Design" Archived April 1, 2016, at the Wayback Machine David Baker online seminar: "Design of New Protein Functions" Archived April 1, 2016, at the Wayback Machine

==== MeSH D12.776.377.715.085 – alpha-globulins ==== MeSH D12.776.377.715.085.050 – alpha 1-antichymotrypsin MeSH D12.776.377.715.085.085 – alpha 1-antitrypsin MeSH D12.776.377.715.085.100 – alpha-macroglobulins MeSH D12.776.377.715.085.118 – antiplasmin MeSH D12.776.377.715.085.125 – antithrombin iii MeSH D12.776.377.715.085.214 – ceruloplasmin MeSH D12.776.377.715.085.394 – haptoglobins MeSH D12.776.377.715.085.450 – heparin cofactor ii MeSH D12.776.377.715.085.640 – orosomucoid MeSH D12.776.377.715.085.740 – progesterone-binding globulin MeSH D12.776.377.715.085.750 – retinol-binding proteins MeSH D12.776.377.715.085.901 – transcortin

Sources: en.wikipedia.org

Related pages on this site

Further detail

For centuries, the Danes and Saxons had regarded each other as kindred peoples, sharing the same belief in the Germanic pantheon and frequently intermarrying, especially among the elite. Thus, the defeated Saxon warleader Widukind sought refuge with his father-in-law, Danish king Sigfred. The Royal Frankish Annals mentions that Widukind received substantial aid from Sigfred, though the exact nature of this aid is not explicitly stated. However, the chronicles do note that Sigfred and Charlemagne brokered a peace agreement some years later, indicating that Sigfred, upon hearing Widukind's plea, may have mustered his army and joined the war on the side of the Saxons. In response to the Danes' involvement in the war, Charlemagne seems to have recruited the Obotrites by promising them the Saxon portion of Holstein. This alliance with Charlemagne shifted the balance of power in the region. In 782, after another defeat of the Saxons, Charlemagne ordered the mass execution of 4,500 Saxons, an atrocity that became known as the Massacre of Verden. Following this brutal act, Charlemagne was nicknamed the "Butcher of Saxons" or "Saxonslaughterer." In 796, despite Saxony being fully under Frankish rule, the Saxons rose once more, supported by the Danes. The rebellion was triggered by the forced conscription of Saxons for the Frankish wars against the Avars. Moreover, Charlemagne, in alliance with the Obotrites, planned to subjugate the Danes, now led by King Gudfred Sigfredson. However, Gudfred struck first.

=== Portion size irregularities === Some customers took to the social media platform TikTok accusing Chipotle of reducing portion sizes. In June 2024, a Wells Fargo analyst and his team set investigated the matter and ordered 75 identically configured items from 8 different Chipotle locations in New York City. The team weighed each bowl and reported that portion sizes varied widely, ranging from 14 to 27 ounces (400 to 770 g) with a median weight of 21.5 ounces (610 g).

ASR-2001 (2CB-5PrO) is a propoxy TWEETIO and another notable analogue of 2C-B which is under development for treatment of psychiatric disorders. FLY derivatives of 2C-B like 2C-B-FLY, 2C-B-DRAGONFLY, and 2C-B-BUTTERFLY are analogues in which the methoxy groups of 2C-B on the phenyl ring have been cyclized into furan or other rings to form benzodifuran and other tricyclic compounds. 2-OH-2C-B is the 2-O-desmethylated analogue of 2C-B and shows similar potency as a serotonin 5-HT2A receptor agonist in vitro. Cyclized phenethylamine derivatives of 2C-B in which the side chain has been cyclized in some way include DOB-CR (2C-B-CR), 2CB-Ind, 2C-B-5-hemiFLY-α6 (BNAP), 2CB7 (2C-B-5-hemiFLY-β7), TCB-2 (2CBCB), 2C-B-PYR, 2C-B-3PIP, 2C-B-3PIP-NBOMe, 2C-B-3PIP-POMe, 2CBecca, 2CJP, 2CLisaB, ZC-B, 2C-B-aminorex (2C-B-AR), and 2C-B-morpholine (2C-B-MOR), among others. Other related cyclized compounds, while not technically phenethylamines or 2C-B derivatives, include 2C-B-BZP and 2C-B-PP. A notable positional isomer of 2C-B is the scaline and mescaline analogue 4-bromomescaline (4-Br-3,5-DMPEA). Deuterated isotopologues of 2C-B such as 2CB-2OCD3 (2-trideuteromethoxy-2C-B), 2CB-5OCD3 (5-trideuteromethoxy-2C-B), and hexadeutero-2C-B (2,5-di(trideuteromethoxy)-2C-B) among others have been described.

== Occurrence == All isotopes of radium have half-lives much shorter than the age of the Earth, so that any primordial radium would have decayed long ago. Radium nevertheless still occurs in the environment, as the isotopes 223Ra, 224Ra, 226Ra, and 228Ra are part of the decay chains of natural thorium and uranium isotopes; since thorium and uranium have very long half-lives, these daughters are continually being regenerated by their decay. Of these four isotopes, the longest-lived is 226Ra (half-life 1600 years), a decay product of natural uranium. Because of its relative longevity, 226Ra is the most common isotope of the element, making up about one part per trillion of the Earth's crust; essentially all natural radium is 226Ra. Thus, radium is found in tiny quantities in the uranium ore uraninite and various other uranium minerals, and in even tinier quantities in thorium minerals. One ton of pitchblende typically yields about one seventh of a gram of radium. One kilogram of the Earth's crust contains about 900 picograms of radium, and one liter of sea water contains about 89 femtograms of radium.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD9604 derived from?

AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.

Is AOD9604 approved as a medicine?

It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.

Does AOD9604 raise IGF-1 levels?

In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.

Network